In this murine model, early CD19-negative relapse did not imply a lineage switch; CD19 was lost by an alternative splicing mechanism, and ALL cells maintained the rest of their pre-CAR exposure phenotype. This evidence concerns the gene CD19 and acute lymphoblastic leukemia.